严重COVID-19患者初级保健地塞米松治疗良好结局病例系列报告表1
严重COVID-19患者在初级保健中采用地塞米松方案治疗的病例系列报告表格数据，展示良好治疗结局。
基本信息
资源简介
严重COVID-19患者初级保健地塞米松治疗良好结局病例系列报告表1
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 677.31 KB，主题涵盖 COVID-19、coronavirus、SARS-CoV-2、dexamethasone、corticosteroids，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table1_Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report.DOCX》。配套论文《Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019》发表于 Anesthesia & Analgesia（2020），DOI：10.1213/ANE.0000000000005292。源站首次发布：2021-08-12。
【数据内容】
源站原始描述：Even in 2021, coronavirus disease 2019 (COVID-19) remains a major global health concern, especially in developing countries. The burden of this disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which affects not only primary respiratory but also other organ systems, keeps rising as the pandemic continues. Primary health care centers are the first line where COVID-19 patients are managed and should be able to manage the vast majority of them successfully. In this pa…
【数据结构与技术规格】
文件数 1 个，合计 677.31 KB。Table1_Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case S.DOCX：application/vnd.openxmlformats-officedocument.wordprocessingml.document，677.31 KB。数据集 DOI：10.3389/fphar.2021.684537.s001。
【主题与分类】
源站学科分类：Basic Pharmacology、Clinical Pharmacology and Therapeutics、Clinical Pharmacy and Pharmacy Practice、Pharmaceutical Sciences、Pharmacogenomics、Pharmacology。主题标签：COVID-19、coronavirus、SARS-CoV-2、dexamethasone、corticosteroids、primary health care、treatment。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://frontiersin.figshare.com/articles/dataset/Table1_Beneficial_Treatment_Outcomes_of_Severe_COVID-19_Patients_Treated_Entirely_in_Primary_Care_Settings_With_Dexamethasone_Including_Regimen_Case_Series_Report_DOCX/15154080
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Vukoja, Damir; Jurić, Andrea; Erkapić, Zdravka; Pejić, Tomislav; Zovko, Željko; Juričić, Josipa; et al. (2021). Table1_Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report.DOCX. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-05-30，引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Table1_Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report.DOCX
- DOI：10.3389/fphar.2021.684537.s001
- 发布日期：2021-08-12
- 文件数：1 个
- 文件总体积：677.31 KB
- 源站页面：https://frontiersin.figshare.com/articles/dataset/Table1_Beneficial_Treatment_Outcomes_of_Severe_COVID-19_Patients_Treated_Entirely_in_Primary_Care_Settings_With_Dexamethasone_Including_Regimen_Case_Series_Report_DOCX/15154080
命令行下载
curl -L -o "Table1_Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case S.DOCX" "https://ndownloader.figshare.com/files/29110158"
文件清单
Table1_Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case S.DOCX（677.31 KB）
文件总体积 677.31 KB（源站 API 实测）。
数据说明
Even in 2021, coronavirus disease 2019 (COVID-19) remains a major global health concern, especially in developing countries. The burden of this disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which affects not only primary respiratory but also other organ systems, keeps rising as the pandemic continues. Primary health care centers are the first line where COVID-19 patients are managed and should be able to manage the vast majority of them successfully. In this paper, we present a case series and concept of beneficial management of even deteriorating and severe patients treated entirely in our primary health center. The management is based on well-timed and rational dexamethasone use, as well as on various other pharmacological and nonpharmacological treatments and interventions, and is supported by provided statistical data. According to the presented experience and positive outcomes achieved, it seems that even deteriorating and severe COVID-19 patients can be treated successfully to some extent or even completely in primary care settings. This kind of approach could be particularly beneficial in conditions of overload of higher-level health care institutions.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fphar.2021.684537.s001（source: https://frontiersin.figshare.com/articles/dataset/Table1_Beneficial_Treatment_Outcomes_of_Severe_COVID-19_Patients_Treated_Entirely_in_Primary_Care_Settings_With_Dexamethasone_Including_Regimen_Case_Series_Report_DOCX/15154080）。
需要用于商业化训练或医疗器械注册（NMPA/FDA）？
公开数据往往缺乏完整的病理回证与专家标注。千方医数集依托陕川双基地与超十家三甲医院直连，提供完全合规、去标识化、支持注册级质控的专病数据集交易服务。
